ARCHIVES

NCI Cancer Studies In China Intact; Visits Delayed

This article is from The Cancer Letter archive.

Vol. 15 No. 28 | July 14, 1989

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

NCI-Approved Clinical Trials

September 28, 2001

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004